Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Jul
20
2025
 FDA to Overhaul Post-Market Chemical Review Program for Food Chemicals Beveridge & Diamond PC
Jul
19
2025
 FDA Announces Plans to Revoke 52 Standards of Identity for Food Products Keller and Heckman LLP
Jul
19
2025
 FDA Extends Comment Period for Proposed Method for Ranking Chemicals in the Food Supply Keller and Heckman LLP
Jul
19
2025
 FDA Calls on Infant and Children’s Food Brands to Improve Recall Communications Keller and Heckman LLP
Jul
19
2025
 FDA Commissioner Marks His First 100 Days Keller and Heckman LLP
Jul
19
2025
 Cultured Salmon Company Receives “No Questions” Letter From FDA Keller and Heckman LLP
Jul
18
2025
 FDA Authorizes JUUL Labs ENDS Products for U.S. Market Keller and Heckman LLP
Jul
18
2025
 FDA Extends Comment Period on Method for Ranking Chemicals in Food for Post-Market Assessments Bergeson & Campbell, P.C.
Jul
18
2025
 APHIS Updates Practices for Reviewing Petitions Seeking a Determination of Nonregulated Status for Organisms Altered or Produced through Genetic Engineering Bergeson & Campbell, P.C.
Jul
18
2025
 McDermott+ Check-Up – July 18, 2025 McDermott Will & Emery
Jul
17
2025
 Defra Begins Public Consultation on Extending UK REACH Transitional Registration Submission Deadlines Bergeson & Campbell, P.C.
Jul
17
2025
 Ninth Circuit Court of Appeals Affirms EKRA Conviction for Lab Operator and Provides Insight into Key Provisions Mintz
Jul
17
2025
 USDA Launches National Farm Security Action Plan K&L Gates LLP
Jul
17
2025
 Motivation, Expectation of Success Negate Obviousness Presumption in Overlapping Range Case McDermott Will & Emery
Jul
17
2025
 An Increasing Regulatory Maze for Nontraditional Meat Products Womble Bond Dickinson (US) LLP
Jul
17
2025
 DOJ Targets Gender‑Affirming Care under FDCA and FCA: Scrutinizes Off‑Label Drug Use and False Diagnosis Codes Proskauer Rose LLP
Jul
16
2025
 This Week in 340B: July 8 – 14, 2025 McDermott Will & Emery
Jul
16
2025
 Shielding Reproductive Freedom: Uncovering New York’s Law Protecting Providers from Civil and Criminal Liability Epstein Becker & Green, P.C.
Jul
16
2025
 Sport On Steroids: Walking the Ethical and Legal Tightrope of the Enhanced Games Squire Patton Boggs (US) LLP
Jul
15
2025
 PANNA Files Writ of Mandamus against EPA for Failing to Respond to Petition to Cancel Organophosphate Pesticides Bergeson & Campbell, P.C.
Jul
15
2025
 Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development Foley & Lardner LLP
Jul
15
2025
 Consumer Compass Newsletter- July 2025 Greenberg Traurig, LLP
Jul
15
2025
 Is Your Enantiomer Possessed? Patenting of Enantiomers – Does Written Description Require More Than Actual Possession? Mintz
Jul
15
2025
 Device Patents in the Orange Book: May 21, 2025, FTC Warning Letters Appear to have Minimal Impact Polsinelli PC
Jul
14
2025
 Latest Moves by Federal Agencies Regarding Gender-Affirming Care: Risks Mount for Providers Epstein Becker & Green, P.C.
Jul
14
2025
 How Much Plastic is Too Much? Class Action Plaintiffs Skip the Homework and Fail the Test Hunton Andrews Kurth
Jul
14
2025
 FDA: Commissioner’s National Priority Voucher Program Aims to Streamline Some Drug Reviews Foley & Lardner LLP
Jul
12
2025
 White House OSTP Issues Agency Guidance for Gold Standard Science Bergeson & Campbell, P.C.
Displaying 1 - 28 of 12443
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters